Thomas J. Schall

Thomas J. Schall

Company: ChemoCentryx

Job title: President, Chief Executive Officer & Chairman of the Board


Success Stories & Lessons Learned: TAVNEOS (Avacopan) – an Oral Inhibitor of the Complement C5a Receptor for the Treatment of ANCAAssociated Vasculitis 9:00 am

Providing a disease and biology overview Sharing experiences from non-clinical and clinical development Addressing lessons learned from the journeyRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.